Parallel Industries Stock

Parallel Industries EBITDA per Employee

The EBITDA per Employee of Parallel Industries (EAPH) as of Aug 7, 2026 is -37,708.40 USD. In the previous year, EBITDA per Employee was -64,634.20 USD — a change of -41.66% (higher).

EBITDA per Employee

-37,708.40USD

YoY

-41.66%

Last updated:

EBITDA per Employee of Parallel Industries is 2026 -37,708.40 USD. EBITDA per Employee of Parallel Industries was 2025 -64,634.20 USD. It decreases by -41.66% higher compared to the previous year.
Access this data via the Eulerpool API

Parallel Industries Stock analysis

What does Parallel Industries do? Easton Pharmaceuticals Inc. is a Canada-based company specializing in the healthcare sector and alternative medicines. It was founded in 1997 and has been listed on the Canadian Securities Exchange since 2014. The company distributes its products in the United States, Canada, Mexico, Europe, and Asia, offering a wide range of products and services including medications, medical devices, cosmetics, supplements, and agricultural products. It operates in various sectors such as the pharmaceutical industry, cosmetics industry, agricultural industry, and medical devices industry. The main business areas of the company are pharmaceuticals and cosmetic products, offering medications for neuropathic pain, chronic fatigue pain, arthritis, as well as cosmetic products with organic ingredients tailored to specific skin needs. Easton Pharmaceuticals also has a presence in the agricultural market, providing fertilizers and pesticides to promote plant growth and increase crop yields. Additionally, the company offers medical devices such as wound dressings, splints, and bandages for injury treatment. It has also invested in real estate for the development of large shopping centers and hotels. The company's business model focuses on providing products and services specifically tailored to the needs of individuals preferring alternative medicines and beauty products. Easton Pharmaceuticals continually strives to expand its brands and introduce new products to the market, while collaborating with other companies to find innovative solutions to medical and health-related problems. In 2020, Easton Pharmaceuticals entered the cannabis sector by signing an agreement with a Canadian company for hemp seed production and marketing. Overall, Easton Pharmaceuticals is a multi-sector company aiming to offer products and services tailored to specific individuals' needs, with a reputation in the industry and a commitment to expanding its presence in the future. Parallel Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parallel Industries stock

EBITDA per Employee of Parallel Industries is -37,708.40 USD in 2026.

EBITDA per Employee of Parallel Industries changed from -64,634.20 USD to -37,708.40 USD, representing a -41.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Parallel Industries since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Parallel Industries historically and in real time.

Access this data via the Eulerpool API

Workforce — Parallel Industries

All Key Metrics — Parallel Industries